CNBC Top Stories

Ahead of his death last month, billionaire Charlie Munger shared his best tips for success and longevity. Among them: It's OK to cry, but never give up.

No matter how rude your in-laws are, it's not your job to reprimand them, one expert says.

In November, National Geographic released The Cool List for 2024 which named the 30 most exciting places to visit next year.

The NFL and Olympic athletes are turning to artificial intelligence for an extra boost in their training and recovery.

The era of free dating apps may be over: Companies are trying to boost revenue, while single people increasingly feel apps are the only way to find love.

Friday's rally pushed the S&P 500 to a new 2023 high. Looking ahead, it's all about earnings and the economy.

Paying student loans often means not putting away enough money for retirement and missing out on a company 401(k) match, but a new law will change that.

Although generative AI models may be capable of writing emails and reviewing code, these tech experts don't see them replacing humans any time soon. Here's why.

The holiday season can come with a heavy dose of stress at work, but paid time off and a supportive company culture can make a difference.

Whether they paid down debt or saw the value of their assets grow, U.S. households' overall wealth grew during the Covid-19 pandemic.

The Ray-Ban Meta smart glasses came out in October, and we reviewed them for you.

McDonald's held an investor day Wednesday that focused on the company's long-term future, but the near term could bring more turbulence.

Palliser Capital has a history of working with management to bring change.

CNBC's Jim Cramer told investors what to focus on next week on Wall Street.

EU institutions spent the week hashing out proposals to come up with an agreement on how to regulate tools like ChatGPT.

Automakers are reconsidering the viability of hybrid vehicles to appease consumer demand and avoid costly penalties related to federal fuel economy standards.

Paramount shares surged Friday following reports that RedBird and Skydance were exploring a potential takeover.

Investors assessed the latest U.S. jobs report on Friday.

An expert witness retained by the defense in the civil fraud trial of former President Donald Trump said he has been paid nearly $900,000 for his work.

Casgevy uses the Nobel Prize-winning technology CRISPR to treat sickle cell disease, a blood disorder that affects about 100,000 Americans.